EPHA7 and cancer: We also gave consideration to EPHA7, another member of the ephrin type A receptor family: despite not corresponding FDR-adjusted p-value cut-off (FDR = 0.0599 > 0.05), its expression showed a 3-fold decrease in early invasive cancer compared to CIN3/cancer in situ.